{"id":"https://openalex.org/W2886595387","doi":"https://doi.org/10.1021/acs.jmedchem.8b00921","title":"Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer","display_name":"Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer","publication_year":2018,"publication_date":"2018-08-07","ids":{"openalex":"https://openalex.org/W2886595387","doi":"https://doi.org/10.1021/acs.jmedchem.8b00921","mag":"2886595387","pmid":"https://pubmed.ncbi.nlm.nih.gov/30086626"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.8b00921","doi":"https://doi.org/10.1021/acs.jmedchem.8b00921","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.8b00921","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021286275","display_name":"Johnny Y. Nagasawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johnny Nagasawa","raw_affiliation_strings":["Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059378712","display_name":"Steven P. Govek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Govek","raw_affiliation_strings":["Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mehmet Kahraman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehmet Kahraman","raw_affiliation_strings":["Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065142951","display_name":"Andiliy G. Lai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andiliy Lai","raw_affiliation_strings":["Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072118690","display_name":"C\u00e9line Bonnefous","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Celine Bonnefous","raw_affiliation_strings":["Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007455917","display_name":"Karensa L. Douglas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karensa Douglas","raw_affiliation_strings":["Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006915014","display_name":"John Sensintaffar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Sensintaffar","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035337955","display_name":"Nhin Lu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nhin Lu","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072729167","display_name":"KyoungJin Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KyoungJin Lee","raw_affiliation_strings":["Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050565684","display_name":"Anna M. Aparicio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Aparicio","raw_affiliation_strings":["Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108468666","display_name":"Josh Kaufman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josh Kaufman","raw_affiliation_strings":["Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001637232","display_name":"Jing Qian","orcid":"https://orcid.org/0000-0001-6120-5147","observed_orcids":["https://orcid.org/0000-0001-6120-5147"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Qian","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100518237","display_name":"Gang Shao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gang Shao","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006279759","display_name":"Rene Y. Prudente","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rene Prudente","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037379407","display_name":"James D. Joseph","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James D. Joseph","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012291117","display_name":"Beatrice D. Darimont","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beatrice Darimont","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087085239","display_name":"Daniel Brigham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Brigham","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006236634","display_name":"Kate Maheu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kate Maheu","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014567706","display_name":"Richard A. Heyman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Heyman","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077906047","display_name":"Peter J. Rix","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Rix","raw_affiliation_strings":["Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079488873","display_name":"Jeffrey H. Hager","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey H. Hager","raw_affiliation_strings":["Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102820332","display_name":"Nicholas D. Smith","orcid":"https://orcid.org/0000-0001-5791-8849","observed_orcids":["https://orcid.org/0000-0001-5791-8849"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Nicholas D. Smith","raw_affiliation_strings":["Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":"https://orcid.org/0000-0001-5791-8849","affiliations":[{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5102820332"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":4.5986,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.95737826,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"61","issue":"17","first_page":"7917","last_page":"7928"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.9589999914169312},{"id":"https://openalex.org/keywords/chromene-derivatives","display_name":"chromene derivatives","score":0.7490000128746033},{"id":"https://openalex.org/keywords/tamoxifen-resistance","display_name":"tamoxifen resistance","score":0.9539999961853027},{"id":"https://openalex.org/keywords/estrogen-receptor-alpha","display_name":"estrogen receptor alpha","score":0.902999997138977},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7929999828338623},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8970000147819519},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.8019999861717224},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9010000228881836},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.9639122486114502},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.8367477059364319},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.7083993554115295},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6746368408203125},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5818575024604797},{"id":"https://openalex.org/C2777944059","wikidata":"https://www.wikidata.org/wiki/Q903917","display_name":"Selective estrogen receptor modulator","level":5,"score":0.5802542567253113},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.5770245790481567},{"id":"https://openalex.org/C172313692","wikidata":"https://www.wikidata.org/wiki/Q14902310","display_name":"Estrogen receptor alpha","level":5,"score":0.5662548542022705},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47865593433380127},{"id":"https://openalex.org/C2776067312","wikidata":"https://www.wikidata.org/wiki/Q50429983","display_name":"Antiestrogen","level":5,"score":0.47666457295417786},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.4751560389995575},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3910643458366394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3679591417312622},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35736578702926636},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24685925245285034}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001578","descriptor_name":"Benzopyrans","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020845","descriptor_name":"Selective Estrogen Receptor Modulators","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020845","descriptor_name":"Selective Estrogen Receptor Modulators","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047628","descriptor_name":"Estrogen Receptor alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.8b00921","doi":"https://doi.org/10.1021/acs.jmedchem.8b00921","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.8b00921","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:30086626","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30086626","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W2013956549","https://openalex.org/W2036673057","https://openalex.org/W2037460676","https://openalex.org/W2048501545","https://openalex.org/W2063712126","https://openalex.org/W2073727823","https://openalex.org/W2077448555","https://openalex.org/W2089595068","https://openalex.org/W2117385681","https://openalex.org/W2132859347","https://openalex.org/W2145086511","https://openalex.org/W2156009048","https://openalex.org/W2180265416","https://openalex.org/W2258559299","https://openalex.org/W2323968754","https://openalex.org/W2580935506","https://openalex.org/W2791894234","https://openalex.org/W2801547004","https://openalex.org/W2802285866","https://openalex.org/W4244519136","https://openalex.org/W4254152438"],"related_works":["https://openalex.org/W2323968754","https://openalex.org/W2986619859","https://openalex.org/W2904445846","https://openalex.org/W4361279964","https://openalex.org/W2019311111","https://openalex.org/W4254025557","https://openalex.org/W2060004930","https://openalex.org/W3094721087","https://openalex.org/W3084846649","https://openalex.org/W2138154153"],"abstract_inverted_index":{"About":[0],"75%":[1],"of":[2,73,77,81,100,148],"breast":[3,102,150],"cancers":[4],"are":[5],"estrogen":[6,35],"receptor":[7,36],"alpha":[8],"(ER-\u03b1)":[9],"positive,":[10],"and":[11,23,42,45,88],"women":[12],"typically":[13],"initially":[14],"respond":[15],"well":[16],"to":[17,141],"antihormonal":[18,55],"therapies":[19],"such":[20,91],"as":[21,92],"tamoxifen":[22],"aromatase":[24],"inhibitors,":[25],"but":[26],"resistance":[27],"often":[28],"emerges.":[29],"Fulvestrant":[30],"is":[31],"a":[32,78,97],"steroid-based,":[33],"selective":[34],"degrader":[37],"(SERD)":[38],"that":[39,65,130],"both":[40],"antagonizes":[41],"degrades":[43],"ER-\u03b1":[44,74,132],"shows":[46],"some":[47],"activity":[48],"in":[49,85,96,135,146],"patients":[50],"who":[51],"have":[52],"progressed":[53],"on":[54],"agents.":[56],"However,":[57],"fulvestrant":[58],"must":[59],"be":[60],"administered":[61],"by":[62],"intramuscular":[63],"injections":[64],"limit":[66],"its":[67],"efficacy.":[68],"We":[69],"describe":[70],"the":[71,136],"optimization":[72],"degradation":[75,106,120,133],"efficacy":[76,107,121,134],"chromene":[79],"series":[80],"ER":[82],"modulators":[83],"resulting":[84],"highly":[86],"potent":[87],"efficacious":[89],"SERDs":[90],"14n.":[93],"When":[94],"examined":[95],"xenograft":[98],"model":[99],"tamoxifen-resistant":[101,149],"cancer,":[103],"14n":[104],"(ER-\u03b1":[105,119],"=":[108,122],"91%)":[109],"demonstrated":[110],"robust":[111,144],"activity,":[112],"while,":[113],"despite":[114],"superior":[115],"oral":[116],"exposure,":[117],"15g":[118],"82%)":[123],"was":[124],"essentially":[125],"inactive.":[126],"This":[127],"result":[128],"suggests":[129],"optimizing":[131],"MCF-7":[137,155],"cell":[138],"line":[139],"leads":[140],"compounds":[142],"with":[143],"effects":[145],"models":[147],"cancer":[151],"derived":[152],"from":[153],"an":[154],"background.":[156]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-08-22T00:00:00"}